Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vardenafil dihydrochloride (Levitra) is a new type PDE inhibitor with IC50 of 0.7 and 180 nM for PDE5 and PDE1, respectively.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | お問い合わせ | ¥ 10,500 |
50 mg | お問い合わせ | ¥ 19,500 |
100 mg | お問い合わせ | ¥ 35,500 |
200 mg | お問い合わせ | ¥ 62,000 |
1 mL * 10 mM (in DMSO) | お問い合わせ | ¥ 18,500 |
説明 | Vardenafil dihydrochloride (Levitra) is a new type PDE inhibitor with IC50 of 0.7 and 180 nM for PDE5 and PDE1, respectively. |
ターゲット&IC50 | PDE5:0.7 nM (Cell-free), PDE1:180 nM (Cell-free) |
別名 | Levitra, Vardenafil Hydrochloride |
分子量 | 561.52 |
分子式 | C23H34Cl2N6O4S |
CAS No. | 224789-15-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 10 mg/mL (17.27 mM)
Ethanol: 16 mg/mL (27.6 mM)
DMSO: 93 mg/mL (160.6 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vardenafil dihydrochloride 224789-15-5 Metabolism PDE cGMP Levitra erectile dysfunction impotence Vardenafil Pharmacokinetics erectile selective zucker diabetic fatty rats inhibit smooth diabetes Inhibitor Endogenous Metabolite hepatitis dysfunction muscle Vardenafil Hydrochloride stimulation Vardenafil Dihydrochloride Phosphodiesterase (PDE) inhibitor